September 7 Health Systems Stroke Study provides insights on ideal DOAC timing for patients with AFib post stroke PT September 2023 The optimum time to resume or initiate direct oral anticoagulants (DOAC) after an acute ischemic stroke in patients with AFib remains unclear. Corey Diamond, PharmD
September 7 Health Systems Pharmacogenomics Pharmacogenomics in the ambulatory care setting bodes well for patients, providers PT September 2023 New research continues to support the integration of pharmacogenomics into clinical practice. Loren Bonner
September 7 Health Systems HCV National infectious disease organizations update guidance on hepatitis C PT September 2023 The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America recently released updated guidance on testing, treating, and managing hepatitis C. Olivia C. Welter, PharmD
October 7 Health Systems Liver Failure SCCM releases new guidance for patients with liver failure in ICU PT October 2023 The Society of Critical Care Medicine (SCCM) has recently released the second part of their guidance on the management of acute liver failure (ALF) and acute-on-chronic liver failure (ACLF) in the ICU. Corey Diamond, PharmD
October 7 Health Systems Blood Pressure Study reaffirms detrimental effects of aggressive BP treatment in hospitalized patients PT October 2023 Despite a body of continually growing evidence against the practice of aggressive BP treatment in hospitalized patients, some health systems still take an intensive approach to managing inpatient BP. Olivia C. Welter, PharmD
October 7 Health Systems Heart Failure Are there benefits to adding hydrochlorothiazide to loop diuretics for patients with acute heart failure? PT October 2023 Recent study findings highlight an alternative approach to combined diuretic treatment in patients with acute heart failure. Maya A. Harris, PharmD
November 7 Health Systems Renal Failure Researchers develop new PIRRT antimicrobial dosing recommendations PT November 2023 Prolonged intermittent renal replacement therapy (PIRRT)—dialysis sessions given over 6 to 12 hours—is an increasingly used treatment strategy for critically ill patients with acute kidney injury. Corey Diamond, PharmD
November 7 Health Systems Multiple Scleroris Specialty pharmacies step up to successfully manage patients with multiple sclerosis PT November 2023 Arecent study conducted across multiple health-system specialty pharmacy sites found that pharmacist interventions can be beneficial for patients with multiple sclerosis (MS) who are on disease-modifying therapies (DMTs). Olivia C. Welter, PharmD